Release Date: 20/05/10 09:39 Summary: Notice of General Meeting and Explanatory Memorandum Price Sensitive: No Download Document 4.65MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%